Dalmia Bharat Enterprises

Similar documents
EBITDA 5,076 3, , EBITDA

Dalmia Bharat Enterprises

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Indian Oil Corporation

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

Institutional Equities

Jamna Auto Industries

EBITDA 6,223 6,511 (4.4) 5, EBITDA

Gillette India. Institutional Equities. 1QFY18 Result Update

Colgate-Palmolive (India)

Dalmia Bharat Enterprises

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

Punjab National Bank

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

EBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA

Indian Oil Corporation

Punjab National Bank

Bata India. Institutional Equities. 1QFY19 Result Update BUY

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

The Ramco Cements. Institutional Equities. Event Update BUY

Institutional Equities

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

Institutional Equities

EBITDA 5,019 4,211 5, EBITDA

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Institutional Equities

Institutional Equities

Institutional Equities

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Institutional Equities

Institutional Equities

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

2,09,057 1,85,859 2,17, (4.1) NIM

3,746 2,551 3, NIM

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

Bharat Financial Inclusion

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY.

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

18,948 15,784 18, NIM

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

9,500 7,914 8, NIM

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Dabur India. Institutional Equities. 1QFY19 Result Update

Institutional Equities

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

Institutional Equities

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

93,707 77,814 90, NIM

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Institutional Equities

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature.

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

Institutional Equities

Initiating Coverage. Uflex Ltd.

Institutional Equities

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

Muthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

Punjab National Bank

Muthoot Finance. Institutional Equities. 1QFY19 Result Update

9,251 7,812 8, NIM

Punjab National Bank

Punjab National Bank

E&P To Stay Strong; Consumer Segment To Revive

State Bank of India. Institutional Equities. 3QFY19 Result Update BUY

Institutional Equities

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

9,807 8,007 9, NIM

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514

South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018

Operating expenses tracked lower than core total income growth as ABL displayed continued

State Bank of India. Institutional Equities. 1QFY18 Result Update

Institutional Equities

Institutional Equities

Manappuram Finance. Institutional Equities. 2QFY19 Result Update BUY

Hindustan Unilever. Institutional Equities. 3QFY18 Result Update BUY

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

Federal Bank. Institutional Equities. Management Meet Update

Hindustan Unilever. Institutional Equities. 2QFY19 Result Update

Swiss Glascoat Equipments

Cement Sector 27 February 2018

Sun Pharmaceutical Industries

Transcription:

Result Update Dalmia Bharat Enterprises 1 November 218 Reuters: DALA.BO; Bloomberg: DBEL IN Performance In Line; Stock Under Review Post Odisha Cement Amalgamation Dalmia Bharat Enterprises (DBEL) reported performance in line with expectation backed by YoY double-digit volume growth. Volume grew ~13.5% YoY to 4.13mnmt (in line with our estimate of 4.8mnmt), contributed by its key markets. Realisation gains (unadjusted to incentive income), grew ~6% YoY to Rs5,225/tn which was offset by higher- than-estimated cost over-run of ~12% at Rs4,283/tn. Overall revenues grew ~17% YoY to ~Rs21.6bn. Higher operating costs was because of higher energy costs (combined with raw material costs to neutralise the inventory impact) that increased ~16% to Rs2,44/tn. Other expenditure jumped 34% YoY to Rs3.68bn and effectively, EBITDA declined ~11% YoY to Rs3.89bn versus ~Rs4.4bn in (marginally below our estimate of ~Rs4.5bn). EBITDA/tn fell 19% to Rs915/tn compared with Rs1,13/tn as cost inflation offset the benefit of realisation gains and hurt the performance. Following the amalgamation of DBEL and Odisha Cement, higher interest costs and depreciation are not comparable with. Effectively, DBEL incurred a loss of 65mn before tax. Positive tax impact helped the company to post a marginal increase in PAT at Rs2mn. We have put the DBEL stock under review from our Sell rating earlier following amalgamation of the two companies. We will revisit our earnings estimates after taking into account the impact of the amalgamation and come out with our revised rating (if it is changed) and a fresh target price on DBEL. Higher volume growth: Volume was up ~14% YoY at 4.13mnmt (~3.64mnmt in ) on account of good demand in the eastern region and revival in the southern region. Realisation unadjusted to the incentives (Rs4mn in ) increased by ~6% YoY to Rs5,225/tn. Cost inflation offsets realisation gains: Energy costs (combined with raw material costs) rose ~16% YoY (energy costs up 24% YoY) on account of high pet-coke prices. The overall pet-coke usage was 57% in. Energy cost inflation continued, despite the shift in fuel mix to domestic fuel/lignite. Other expenditure shot up sharply by ~35% to Rs3.68bn YoY. Logistics costs were up ~7 YoY at Rs949/tn because of higher diesel prices. Effectively, overall operating costs rose 11.5% YoY/~5. QoQ to Rs4,283/tn. Ratings and estimates under review: We have placed the DBEL stock under review from our Sell rating earlier following the amalgamation of Odisha Cement with DBEL. We will revisit our earnings estimates after taking into account the impact of the amalgamation and come out with a revised rating (if it is changed) and a fresh target price on DBEL shortly. UNDER REVIEW Sector: Cement CMP: Rs2,9 Milind Raginwar Research Analyst milind.raginwar@nirmalbang.com +91-22-6273 8172. Key Data Current Shares O/S (mn) 89.2 Mkt Cap (Rsbn/US$bn) 187.8/2.5 52 Wk H / L (Rs) 3,35/1,923 Daily Vol. (3M NSE Avg.) 9,816 Price Performance (%) 1 M 6 M 1 Yr Dalmia Bharat (9.2) (3.9) (29.6) Nifty Index (5.1) (3.4).4 Source: Bloomberg Y/E March (Rsmn) YoY % QoQ % Net sales 21,58 18,337 17.7 23,676 (8.9) Operating expenses 17,69. 13,985.9 26.5 18,436.3 (4.) EBITDA 3,89 4,351 (.6) 5,24 (25.8) EBITDA margin (%) 18 24 (57bps) 22 (4bps) Other income 74 922 (19.7) 432 71.1 Interest costs* 2,25 1,911 17.7 1,62 38.9 Depreciation* 3,3 1,547 95.9 1,798 68.6 PBT* (65) 1,814 (135.8) 2,254 (128.8) Non-recurring items.. PBT (after non-recurring items)* (65) 1,814 (135.8) 2,254 (128.8) Tax* (67) 584 (214.7) 773 (186.6) Reported PAT* 2 1,23 (98.4) 1,481 (98.6) Adjusted PAT* 2 1,37 (98.1) 1,243 (98.4) NPM (%).1 5.7 (556bps) 5.2 (516bps) Adjusted EPS* (Rs).2 11.7 (98.1) 14. (98.4) Source: Company, Nirmal Bang Research * Not comparable with / due to amalgamation impact

Exhibit 1: Operational details (Rs) YoY % QoQ % E Deviation % Volume (mnmt) 4.13 3.6 13.5 4.5 (8.4) 4.8 1.3 Cement realisation (net of freight) (Rs/mt) 5,225 4,945 5.7 4,881 7.1 4,875 7.2 Operating costs (Rs/mt) 4,283 3,842 11.5 4,88 4.8 4,129 3.7 EBITDA (Rs/mt) 915 1,13 (19.1) 1,135 (19.4) 994 (7.9) Source: Company, Nirmal Bang Research Exhibit 2: Detailed quarterly financials (Rsmn) YoY % QoQ % E Deviation % Net sales 21,58 18,337 17.7 23,676 (8.9) 2,885 3.3 Expenditure Change in stock (68) (119) 47.5 (218) 211.5 (359) 89.4 Clinker purchases 32 393 (18.6) 177 8.5 81 295.1 Raw material costs 4,5 3,117 44.7 4,455 1.2 4,219 6.9 Power & fuel expenses 4,29 3,44 4.9 3,95 8.6 3,649 17.6 Freight costs 3,92 3,217 21.9 4,651 (15.7) 4,44 (3.1) Employee costs 1,65 1,66 2.8 1,682 (1.9) 1,75 (5.7) Other expenses 3,68 2,729 34.8 3,74 (1.6) 3,45 6.7 Total operating expenses 17,69 13,986 26.5 18,436 (4.) 16,834 5.1 EBITDA 3,89 4,351 (.6) 5,24 (25.8) 4,51 (4.) EBITDA margin (%) 18. 23.7 (57bps) 22.1 (4bps) 19.4 (137bps) Other income 74 922 (19.7) 432 71 855 (13.5) Interest costs* 2,25 1,911 17.7 1,62 39 1,6 39.8 Depreciation* 3,3 1,547 95.9 1,798 69 1,788 69.5 PBT* (65) 1,814 (135.8) 2,254 (129) 1,58 (143.1) Non-recurring items....... PBT (after non-recurring items)* (65) 1,814.4 (135.8) 2,254.3 (129) 1,58. (143.1) Tax* (67) 584. (214.7) 773.4 (187) 354.4 (289.1) Reported PAT* 2. 1,23.4 (98.4) 1,48.9 (99) 1,153.6 (98.3) Adjusted PAT* 2. 1,37.3 (98.1) 1,242.5 (98) 1,13.6 (98.) NPM (%)*.1 5.7 (556bps) 5.2 (516bps) 4.9 (476bps) Adjusted EPS (Rs)*.2 11.7 (98.1) 14. (98) 11.4 (98.) Research * Not comparable with / because of amalgamation impact Source: Company, Nirmal Bang Exhibit 3: Trend in operating costs/mt Operating costs/mt(rs) 2QFY17 YoY % QoQ % Consumption of raw materials 793 72 893 79 931 976 1,16 979 1,5 7.9 2.7 Power and fuel expenses 672 689 688 89 836 826 757 876 1,39 24.2 18.6 Freight costs 86 91 929 936 884 93 1,29 1,31 949 7.4 (8.) Total costs per mt 3,777 3,73 3,587 3,765 3,842 3,943 3,956 4,88 4,283 11.5 4.8 Source: Company, Nirmal Bang Research 2 Dalmia Bharat Enterprises

2QFY16 3QFY16 4QFY16 1QFY17 2QFY17 2QFY16 3QFY16 4QFY16 1QFY17 2QFY17 Exhibit 4: Volume growth continues backed by strong demand in key markets (Rsmn) 5.2 (%) 5. 4.6 4.51 3.9 4. 4.2 4.13 9 4. 3.8 3.4 3.6 3.6 8 2.9 3. 7 3. 6 5 2. 4 3 1. 2. () (1.) (2) Exhibit 5: Realisation (unadjusted to incentive income) gains YoY 5,4 15 5,2 5, 4,8 4,6 4,4 4,2 4, 5 (5) () (15) Volumes (mn mt) Realisations (Rs/mt) Source: Company, Nirmal Bang Research Exhibit 6: EBITDA/tn falls as high cost offsets realisation gains Exhibit 7: Overall cost escalation continues impacting EBITDAM (Rsmn) 1,5 1,3 1, 9 7 5 3 1,112 1,145 1,333 1,13 1,57 1,137 1,135 915 4,4 14 12 4,2 4, 8 6 3,8 4 2 3,6 3,4 (2) (4) 3,2 (6) EBITDA/mt Operating costs/mt (Rs) Source: Company, Nirmal Bang Research Exhibit 8: Freight cost inflation limited 1,5 14 12 1, 95 8 6 9 4 85 2 8 (2) Source: Company, Nirmal Bang Research Exhibit 9: Higher pet-coke prices impact energy costs 1,2 6 1, 5 4 8 3 6 2 4 2 - () Freight costs/mt (Rs) Power & Fuel costs/mt (Rs) Source: Company, Nirmal Bang Research Source: Company, Nirmal Bang Research 3 Dalmia Bharat Enterprises

Apr-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Oct-18 Financials snapshot pre-amalgamation (Financials Under Review post-amalgamation) Y/E Mar (Rsmn) FY16 FY17 FY18P FY19E FY2E Net sales 64,38 74,44 86,792 98,54 5,762 EBITDA margin (%) 24.5 25.7 23.8 25.1 25.1 Adjusted net profit 1,98 2,937 5,498 7,75 8,31 vs consensus (%) - - - (23.1) (33.3) EPS (Rs) 21.5 33.1 61.9 79.7 9.4 growth (%) 1,95.3 53.9 87.2 28.7 13.5 P/E (x) 122.1 79.3 42.4 32.9 29. P/B (x) 8. 6.9 8.2 7.6 7.2 EV/EBITDA (x) 18.4 14.8 13.5 11.3.5 D/E(x) 1.1.8.8.8.8 RoE (%) 4. 5.1 9.7 12.8 13.9 RoCE (%) 9.3.3 11.8 14.5 15.6 Source: Company, Nirmal Bang Research Rating track Date Rating Market price (Rs) Target price (Rs) 26 March 218 Sell 2, 847 2,589 22 May 218 Sell 2,737 2,592 6 June 218 Sell 2,624 2,43 14 August 218 Sell 2,55 2,395 1 November 218 UNDER REVIEW 2,9 - Rating track graph 34 32 3 28 26 24 22 2 18 Not Covered Covered 4 Dalmia Bharat Enterprises

DISCLOSURES This Report is published by Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) for private circulation. NBEPL is a registered Research Analyst under SEBI (Research Analyst) Regulations, 214 having Registration no. INH1436. NBEPL is also a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments. NBEPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. NBEPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in securities Market. NBEPL, its associates or analyst or his relatives do not hold any financial interest in the subject company. NBEPL or its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the subject company. NBEPL or its associates or Analyst or his relatives do not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of this research report. NBEPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. NBEPL or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an officer, director or employee of Subject Company and NBEPL / analyst has not been engaged in market making activity of the subject company. Analyst Certification: Mr. Milind Raginwar, the Research Analyst are the author of this report, hereby certify that the views expressed in this research report accurately reflects my/our personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst(s) principally responsible for the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. 5 Dalmia Bharat Enterprises

Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. NBEPL is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In preparing this research, we did not take into account the investment objectives, financial situation and particular needs of the reader. This research has been prepared for the general use of the clients of NBEPL and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. NBEPL will not treat recipients as customers by virtue of their receiving this report. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject NBEPL & its group companies to registration or licensing requirements within such jurisdictions. The report is based on the information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to correct or update the information or opinions in it. NBEPL or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. NBEPL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This information is subject to change without any prior notice. NBEPL reserves its absolute discretion and right to make or refrain from making modifications and alterations to this statement from time to time. Nevertheless, NBEPL is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Before making an investment decision on the basis of this research, the reader needs to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the company nor the director or the employees of NBEPL accept any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Here it may be noted that neither NBEPL, nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in connection with the use of the information contained in this report. Copyright of this document vests exclusively with NBEPL. Our reports are also available on our website www.nirmalbang.com Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Email Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com +91 22 6273 817 / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com +91 22 6273 823, +91 22 6636 8833 Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com +91 22 6273 8/81, +91 22 6636 8831 Michael Pillai Dealing Desk michael.pillai@nirmalbang.com +91 22 6273 82/83, +91 22 6636 883 Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 31/32, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai-413. Board No. : 91 22 3926 8/1; Fax. : 22 3926 8 6 Dalmia Bharat Enterprises